Literature DB >> 14645836

Are we ready for pandemic influenza?

Richard J Webby1, Robert G Webster.   

Abstract

During the past year, the public has become keenly aware of the threat of emerging infectious diseases with the global spread of severe acute respiratory syndrome (SARS), the continuing threat of bioterrorism, the proliferation of West Nile virus, and the discovery of human cases of monkeypox in the United States. At the same time, an old foe has again raised its head, reminding us that our worst nightmare may not be a new one. In 2003, highly pathogenic strains of avian influenza virus, including the H5N1 and H7N7 subtypes, again crossed from birds to humans and caused fatal disease. Direct avian-to-human influenza transmission was unknown before 1997. Have we responded to these threats by better preparing for emerging disease agents, or are we continuing to act only as crises arise? Here we consider progress to date in preparedness for an influenza pandemic and review what remains to be done. We conclude by prioritizing the remaining needs and exploring the reasons for our current lack of preparedness for an influenza pandemic.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645836     DOI: 10.1126/science.1090350

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  210 in total

Review 1.  Influenza: emergence and control.

Authors:  Aleksandr S Lipatov; Elena A Govorkova; Richard J Webby; Hiroichi Ozaki; Malik Peiris; Yi Guan; Leo Poon; Robert G Webster
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 2.  Notch system in the linkage of innate and adaptive immunity.

Authors:  Toshihiro Ito; Judith M Connett; Steven L Kunkel; Akihiro Matsukawa
Journal:  J Leukoc Biol       Date:  2012-03-29       Impact factor: 4.962

Review 3.  Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.

Authors:  Neetu Singh; Aseem Pandey; Suresh K Mittal
Journal:  Expert Rev Mol Med       Date:  2010-04-29       Impact factor: 5.600

4.  Combining mathematics and empirical data to predict emergence of RNA viruses that differ in reservoir use.

Authors:  C Brandon Ogbunugafor; Sanjay Basu; Nadya M Morales; Paul E Turner
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-06-27       Impact factor: 6.237

5.  Sprouty-Related Ena/Vasodilator-Stimulated Phosphoprotein Homology 1-Domain-Containing Protein-2 Critically Regulates Influenza A Virus-Induced Pneumonia.

Authors:  Toshihiro Ito; Junya Itakura; Sakuma Takahashi; Miwa Sato; Megumi Mino; Soichiro Fushimi; Masao Yamada; Tuneo Morishima; Steven L Kunkel; Akihiro Matsukawa
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

Review 6.  Review: molecular evolution and the feasibility of an avian influenza virus becoming a pandemic strain--a conceptual shift.

Authors:  Dany Shoham
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

Review 7.  Health and economic benefits of an accelerated program of research to combat global infectious diseases.

Authors: 
Journal:  CMAJ       Date:  2004-11-09       Impact factor: 8.262

Review 8.  Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion.

Authors:  Nicole Baumgarth; James W Tung; Leonore A Herzenberg
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

9.  Molecular signatures of virulence in the PB1-F2 proteins of H5N1 influenza viruses.

Authors:  Amber M Smith; Jonathan A McCullers
Journal:  Virus Res       Date:  2013-03-14       Impact factor: 3.303

10.  High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2).

Authors:  William E Severson; Michael McDowell; Subramaniam Ananthan; Dong-Hoon Chung; Lynn Rasmussen; Melinda I Sosa; E Lucile White; James Noah; Colleen B Jonsson
Journal:  J Biomol Screen       Date:  2008-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.